Want to see PRVA full AI Analyst Report?
PRVA Stock Chart & Stats
$21.20
-$0.34(-1.35%)
At close: 4:00 PM EDT
$21.20
-$0.34(-1.35%)
Day’s Range― - ―
52-Week Range$18.92 - $28.82
Previous CloseN/A
Volume332.47K
Average Volume (3M)1.31M
Market Cap
$2.87B
Enterprise Value$3.04B
Total Cash (Recent Filing)$412.20B
Total Debt (Recent Filing)$8.73B
Price to Earnings (P/E)99.8
Beta0.67
Next Earnings
Nov 05, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding127,734,210
10 Day Avg. Volume1,463,419
30 Day Avg. Volume1,314,008
Financial Highlights & Ratios
PEG Ratio2.14
Price to Book (P/B)3.93
Price to Sales (P/S)1.36
P/FCF Ratio17.86
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue1.29
Enterprise Value/Gross Profit16.96
Enterprise Value/Ebitda44.66
Forecast
1Y Price Target
$31.80Price Target Upside50.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)0.26
Revenue Forecast (FY)$2.46B
Bulls Say, Bears Say
Bulls Say
Expanding Physician Network And Attributed LivesPrivia is expanding both its provider network and value-based patient base, increasing the scale of its management platform and the population eligible for shared-savings economics. High retention further supports durable relationships and lowers the execution burden of replacing departing physicians.
Strong Adjusted EBITDA Growth And Operating LeverageRapid adjusted EBITDA growth alongside lower platform costs indicates operating leverage as Privia scales. Continued efficiency in technology, administrative infrastructure, and SG&A can support expanding contribution margins and provide greater internal funding capacity for network growth and market expansion.
Cash-rich, Debt-free Balance SheetThe reported cash balance and absence of debt provide financial flexibility for acquisitions, technology investment, and geographic expansion without depending on incremental borrowing. If the stated EBITDA-to-cash conversion is achieved, Privia should retain meaningful capacity to fund growth internally.
Bears Say
Reported Deterioration In Recent Cash GenerationThe sharp reported reversal from consistently positive historical cash generation to deeply negative TTM operating and free cash flow raises uncertainty around liquidity, provider payments, and execution. Even if partly a reporting anomaly, it warrants caution until cash conversion is demonstrated in subsequent periods.
Thin Current ProfitabilityLow current margins leave limited protection against cost increases, payer changes, or weaker operating execution. Although revenue and profitability have improved from earlier losses, the narrow earnings cushion means relatively small disruptions could materially affect net income and reduce funds available for reinvestment.
Variable Payer Economics And Settlement TimingA meaningful part of Privia’s economics depends on payer contracts, quality performance, medical-cost trends, and shared-savings settlements. Delayed CMS cash and ongoing program changes can create uneven cash conversion, complicate provider payouts, and make results less predictable across the next several quarters.
PRVA FAQ
What was Privia Health Group’s price range in the past 12 months?
Privia Health Group lowest stock price was $18.91 and its highest was $28.82 in the past 12 months.
What is Privia Health Group’s market cap?
Privia Health Group’s market cap is $2.87B.
When is Privia Health Group’s upcoming earnings report date?
Privia Health Group’s upcoming earnings report date is Nov 05, 2026 which is in 15 days.
How were Privia Health Group’s earnings last quarter?
Privia Health Group released its earnings results on Aug 06, 2026. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.067 by $0.003.
Is Privia Health Group overvalued?
According to Wall Street analysts Privia Health Group’s price is currently Undervalued.
Does Privia Health Group pay dividends?
Privia Health Group does not currently pay dividends.
What is Privia Health Group’s EPS estimate?
Privia Health Group’s EPS estimate is 0.09.
How many shares outstanding does Privia Health Group have?
Privia Health Group has 127,734,210 shares outstanding.
What happened to Privia Health Group’s price movement after its last earnings report?
Privia Health Group reported an EPS of $0.07 in its last earnings report, beating expectations of $0.067. Following the earnings report the stock price went down -8.18%.
Which hedge fund is a major shareholder of Privia Health Group?
Currently, no hedge funds are holding shares in PRVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Privia Health Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.80 (50.00% Upside)
$31.80 (50.00% Upside)
Blogger Sentiment
Bullish
PRVA Sentiment 67%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 49.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.10%
12-Months-Change
Fundamentals
Return on Equity
0.01%
Trailing 12-Months
Asset Growth
16.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Privia Health Group
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
PRVA Company Deck
PRVA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong set of operational and financial results — double-digit growth in implemented providers, attributed lives and practice collections, substantial adjusted EBITDA growth and notable margin expansion — supported by a cash-rich, no-debt balance sheet and continued M&A and market expansion. The primary risks discussed were timing-related (possible CMS shared-savings settlement delay and cash-tax timing), a Q2 observation that provider payments grew faster than revenue, and near-term market/payer variability. Management maintained conservative guidance posture for the back half of the year despite raising full-year outlook ranges for several metrics and emphasized AI and scale levers to continue margin improvement.View all PRVA earnings summariesPRVA Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$31.80
▲(50.00% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.87% Insiders
27.94% Mutual Funds
1.45% Other Institutional Investors
43.72% Public Companies and
Individual Investors











